Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News on Pharma

Walgreens confirms plans to sell abortion pills under new FDA rules

Walgreens expects to offer abortion pills after the Food and Drug Administration changed its rules for the drug.

Tribune News Service

Shortage of cold medicines in UK is government’s fault, say pharmacists

Pharmacy leaders cite ministers’ ‘lack of planning’ amid problems obtaining common products

The Guardian - UK

Calpol 'non-existent' as basic medicines run low and flu, Covid and Strep A surge

Health chiefs have issued a warning about low supplies of common cold and flu medicines as pharmacists struggle to get hold of Calpol, throat lozenges and some painkillers

Daily Mirror

From analysis to the latest developments in health,
read the most diverse news in one place.

'We will have something that will do the job': Message from Greater Manchester pharmacy leader amid cold and flu medicines shortage

"People have been only buying it when they need it and that's helping ease the situation."

Manchester Evening News

Supermarkets respond to cold and flu drugs shortage warning

Members of the public have been told by leading pharmacists to not panic and that support for patients will be made available

Manchester Evening News

Oklahoma AG announces 4 new opioid settlements worth $226M

Oklahoma has entered into four new settlements with opioid makers and distributors totaling more than $226 million

The Independent UK

"Not a cough bottle in sight": M.E.N readers share experiences as pharmacy leaders of warn of cold and flu medicines shortages

"Shelves were bare yesterday and tried 4 different places including several chemists and apparently they can't get hold of new stock."

Manchester Evening News

Read news from The Economist, FT, and more,
with one subscription

2 Biotech Stocks to Buy Amid a Blazing Hot Run

A rapidly aging population and the rise in lifestyle diseases drive the biotech industry’s growth. Through their cutting-edge research, biotech companies are coming up with new solutions to develop treatments. Given the solid long-term prospects of the industry, it could be wise to buy fundamentally strong biotech stocks Amgen Inc.…

StockNews.com

Pharmacies warn of medicine shortage but experts urge people not to panic

Pharmacy chiefs have warned of a concerning shortage in cough and cold medicines this winter

Nottingham Post

Warning over shortage of cold and flu medicines as winter bugs spread

The Association of Independent Multiple Pharmacies has said there are supply issues for both branded and unbranded medicines to treat winter illnesses

Chronicle Live

Cold and flu medicine warning issued by pharmacy chiefs

There is a shortage of ‘the very basic’ supplies, says industry group

The Independent UK

Pharmacy bosses issue warning over shortage of cough and cold medicines

Supply issues have been reported over other medicines including HRT and antibiotics

Manchester Evening News

UK running out of cold and cough medicines - but Brits warned not to panic

Pharmacy chiefs have warned of a concerning shortage in cough and cold medicines this winter amid cases of flu and Covid. The Association of Independent Multiple Pharmacies has said shortages are on the back of supply chain issues

Daily Mirror

France suspends internet sales of paracetamol as stocks dwindle

The French government on Wednesday announced an immediate ban on the internet sale of all paracetamol-based painkillers, effective until the end of January. Paracetamol, particularly in forms suitable for children, has been in short supply for the past six months, mainly because of a Chinese ban on the export of…

Radio France Internationale

Get all your
news in one place.

100's of premium titles.
One news app.

Wales Online

Cold and flu medicine shortage alert as UK gripped by winter lurgy

Throat lozenges, cough mixtures and some pain killers in short supply, pharmacy leaders warn

The Independent UK

‘Lack of planning’ blamed for cold and flu medicine shortages

It comes after supply issues with other medicines including HRT and antibiotics.

Asharq Al-Awsat

Saudi Businessman Purchases 12 Camels Worth $32 Million

A Saudi businessman signed a 120 million riyal ($32 million) deal in Riyadh to purchase 12 camels, marking one of the biggest camels' purchase deals in the Gulf. The event coincided with Cristiano Ronaldo joining of Saudi Al-Nassr team. The deal was signed in Dahana Desert, which is hosting the…

Axios

FDA adds a major new twist to the abortion pill fight

Abortion rights advocates say that if the FDA withdraws its mifepristone approval, it would essentially result in a national ban.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Abortion pills can be sold at US pharmacies, the Food and Drug Administration rules

Activists hail the move as ‘a step in the right direction’

Al Jazeera

US FDA allows sale of abortion pills at pharmacies for first time

Regulatory change to expand abortion access comes after more than a dozen states banned abortion.

Axios

Retail pharmacies can offer abortion pills, FDA says

Certified pharmacies can now dispense abortion pills.

ABC News

Clermont pharmacist Grant Oswald wins award for Jugs and Jocks event helping men's mental health

When Grant Oswald noticed he was "sneaking down the path of the black dog", he started a now award-winning mental health event.

The Guardian - UK

The Guardian view on the prime minister’s NHS problem: he’s lost for words

Editorial: The government faces a crisis in a part of the state where voters don’t fully trust it

Birmingham Post

Cramlington's Pharmaron posts widening losses amid increasing costs and competition

Formerly known as Aesica, the Northumberland firm was acquired by China's pharma giant Pharmaron a year ago

StockNews.com

1 Stock That Would Be an Excellent Addition to Your Portfolio for Years to Come

Biopharmaceutical company Pfizer (PFE) is committed to executing its strategies to deliver breakthroughs to patients worldwide. The company saw a solid operational performance in the last reported quarter and raised its full-year 2022 outlook. Given PFE’s strong fundamentals and reliable dividends, this stock could be an ideal long-term investment. Read…

1 … 69 70 71 72

People

Mangeet Kaur BounsMangeet

Alexis McGill Johnson

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

UK Health Security Agency

Food and Drug Administration

Alliance Defending Freedom

47 stories

GenBioPro

30 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.